Literature DB >> 26464617

Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.

Wusong Dong1, Rui Yang2, Jian Yang1, Jun Yang1, Jiawang Ding1, Hui Wu1, Jing Zhang1.   

Abstract

Inflammatory responses are key players in myocardial ischemia/reperfusion (I/R) injury. Our previous studies showed that resveratrol alleviated I/R injury in myocardial I/R animal models, but whether the NALP3 inflammasome pathway contributes to the mechanisms remains to be elucidated. In this study, we explored the modulation effect of resveratrol on myocardial I/R-induced inflammatory responses in rats. Myocardial I/R rat animal models were induced by occlusion of the left anterior descending coronary arteries (LADs) for 30 min, followed by 2 h of reperfusion. Resveratrol was administered in different doses (2.5, 5, and 10 mg/kg) at the same time as the onset of reperfusion. The serum concentrations of the trinitrotoluene (TnT) and MB isoenzyme creatine kinase (CK-MB) were detected using an automatic biochemical analyzer. Myocardial ultrastructure and morphology were observed with an electron microscope and a light microscope. Myocardial ischemia and infarct sizes were evaluated using Evans blue and tetrazolium chloride (TTC) staining. The NALP3, Caspase1, interleukin 1β (IL-1β) and interleukin 18 (IL-18) mRNA levels were evaluated using RT-PCR. The NALP3 and Caspase1 protein expression levels were detected by western blotting. The IL-1β and IL-18 content in peripheral blood was measured by enzyme-linked immunosorbent assay (ELISA). The myocardial structure in myocardial ischemia reperfusion injury (MI/RI) rats was extensively damaged. After preconditioning with different concentrations of resveratrol (2.5, 5 and 10 mg/kg), the pathology and morphology were significantly improved in a dose-dependent manner. Our results showed that resveratrol treatment significantly reduced the infarct volume and myocardial fibrosis, resulting in myocardial cells that lined up in a more orderly fashion and dose-dependent decreases in TnT and CK-MB levels in the serum of the I/R rats. Resveratrol also significantly modulated mRNA and protein levels by down-regulating NALP3 and Caspase1 expression and IL-1β and IL-18 activation. These results suggest that the NALP3 inflammasome is activated during the myocardial I/R injury process and that the secretion of the inflammatory cytokines IL-1β and IL-18 mediates the cascade inflammatory response. Resveratrol may play an important role in protecting the myocardium against I/R injury in rats by inhibiting the expression and activation of the NALP3 inflammatory body. Therefore, the attenuation of the inflammatory response may be involved in the cardioprotective mechanisms of resveratrol in response to myocardial I/R injury.

Entities:  

Keywords:  Caspase1; I/R injury; NALP3; Resveratrol; inflammasome body

Mesh:

Substances:

Year:  2015        PMID: 26464617      PMCID: PMC4583849     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  43 in total

1.  Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.

Authors:  X L Ma; P S Tsao; A M Lefer
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Kinase inhibitors from Polygonum cuspidatum.

Authors:  G S Jayatilake; H Jayasuriya; E S Lee; N M Koonchanok; R L Geahlen; C L Ashendel; J L McLaughlin; C J Chang
Journal:  J Nat Prod       Date:  1993-10       Impact factor: 4.050

3.  Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism.

Authors:  H Arichi; Y Kimura; H Okuda; K Baba; M Kozawa; S Arichi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1982-05       Impact factor: 1.645

4.  Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin.

Authors:  Beata Olas; Barbara Wachowicz; Joanna Saluk-Juszczak; Tomasz Zieliński
Journal:  Thromb Res       Date:  2002-08-15       Impact factor: 3.944

5.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.

Authors:  M R Litt; R W Jeremy; H F Weisman; J A Winkelstein; L C Becker
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

6.  The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.

Authors:  A Valtchanova-Matchouganska; M Gondwe; A Nadar
Journal:  Life Sci       Date:  2004-07-09       Impact factor: 5.037

7.  The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.

Authors:  Annett Halle; Veit Hornung; Gabor C Petzold; Cameron R Stewart; Brian G Monks; Thomas Reinheckel; Katherine A Fitzgerald; Eicke Latz; Kathryn J Moore; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

8.  Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury.

Authors:  Zhuoxiao Cao; Yunbo Li
Journal:  Eur J Pharmacol       Date:  2004-04-05       Impact factor: 4.432

9.  Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol.

Authors:  Ju-Chi Liu; Jin-Jer Chen; Paul Chan; Ching-Feng Cheng; Tzu-Hurng Cheng
Journal:  Hypertension       Date:  2003-11-17       Impact factor: 10.190

10.  Antiplatelet activity of synthetic and natural resveratrol in red wine.

Authors:  A A Bertelli; L Giovannini; D Giannessi; M Migliori; W Bernini; M Fregoni; A Bertelli
Journal:  Int J Tissue React       Date:  1995
View more
  18 in total

1.  Resveratrol alleviates Staphylococcus aureus pneumonia by inhibition of the NLRP3 inflammasome.

Authors:  Suxia Wu; Jianan Huang
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

2.  Ginsenoside Rh2 Inhibits NLRP3 Inflammasome Activation and Improves Exosomes to Alleviate Hypoxia-Induced Myocardial Injury.

Authors:  Zhongwen Qi; Zhipeng Yan; Yueyao Wang; Nan Ji; Xiaoya Yang; Ao Zhang; Meng Li; Fengqin Xu; Junping Zhang
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 3.  The roles of resveratrol on cardiac mitochondrial function in cardiac diseases.

Authors:  Apiwan Arinno; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Eur J Nutr       Date:  2020-05-06       Impact factor: 5.614

4.  Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice.

Authors:  Zaid H Maayah; Abrar S Alam; Shingo Takahara; Shubham Soni; Mourad Ferdaoussi; Nobutoshi Matsumura; Beshay N Zordoky; David D Eisenstat; Jason R B Dyck
Journal:  FEBS Lett       Date:  2021-05-06       Impact factor: 3.864

5.  Recent studies on resveratrol and its biological and pharmacological activity.

Authors:  Yong Joo Kim; Sun Ok Chung; Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2017-04-27       Impact factor: 4.068

Review 6.  Inflammasomes in Tissue Damages and Immune Disorders After Trauma.

Authors:  Perrine Bortolotti; Emmanuel Faure; Eric Kipnis
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

Review 7.  ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.

Authors:  Letteria Minutoli; Domenico Puzzolo; Mariagrazia Rinaldi; Natasha Irrera; Herbert Marini; Vincenzo Arcoraci; Alessandra Bitto; Giovanni Crea; Antonina Pisani; Francesco Squadrito; Vincenzo Trichilo; Daniele Bruschetta; Antonio Micali; Domenica Altavilla
Journal:  Oxid Med Cell Longev       Date:  2016-04-05       Impact factor: 6.543

Review 8.  Resveratrol and Cardiovascular Diseases.

Authors:  Dominique Bonnefont-Rousselot
Journal:  Nutrients       Date:  2016-05-02       Impact factor: 5.717

Review 9.  Protective Effects of Polyphenols against Ischemia/Reperfusion Injury.

Authors:  Martina Cebova; Olga Pechanova
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

Review 10.  Nutraceutical Compounds Targeting Inflammasomes in Human Diseases.

Authors:  Beatriz Castejón-Vega; Francesca Giampieri; José M Alvarez-Suarez
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.